Medifast MED Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Medifast’s reported figures.
Based on trailing twelve months.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medifast's return on equity?
- Medifast (MED) reported return on equity of -9.8% in Q1 2026.
- How has Medifast's return on equity changed year-over-year?
- Medifast's return on equity decreased by 195.5% year-over-year, from -3.3% to -9.8%.
- What is the long-term trend for Medifast's return on equity?
- Over 5 years (2020 to 2025), Medifast's return on equity has grown at a -35.0% compound annual growth rate (CAGR), from 78.5% to -9.1%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.